Lumito
4.70 SEK
0.00 %
Less than 1K followers
LUMITO
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lumito
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 0.1 | ||||||
| EBITDA | -4.9 | -7.7 | -26.2 | -6.6 | -6.0 | -4.0 | -5.8 | -22.4 |
| EBIT | -9.8 | -15.0 | -38.3 | -11.4 | -10.8 | -8.9 | -10.7 | -41.9 |
| EBIT-% | -18,725.0 % | -38,300.0 % | ||||||
| Profit before taxes | -10.8 | -15.5 | -41.6 | -11.8 | -11.3 | -9.5 | -11.2 | -43.9 |
| Net income | -10.8 | -15.5 | -41.6 | -11.8 | -11.3 | -9.5 | -11.2 | -43.9 |